FDA Oncology (@fdaoncology) 's Twitter Profile
FDA Oncology

@fdaoncology

FDA Oncology Center of Excellence expedites medical product development to improve the lives of people with cancer.

ID: 836298809605046278

linkhttp://www.fda.gov/OCE calendar_today27-02-2017 19:35:48

8,8K Tweet

39,39K Takipçi

353 Takip Edilen

FDA Oncology (@fdaoncology) 's Twitter Profile Photo
FDA Oncology
@fdaoncology

3 years ago

Today, FDA approved Enhertu (fam-trastuzumab deruxtecan-nxki) for unresectable or metastatic HER2-low breast cancer, a newly defined subset of HER2-negative breast cancer. This is the first drug approved to treat this subtype. thread 1/3 #bcsm fda.gov/news-events/pr…